Working... Menu

Blood Draw Study for Liver Transplant Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01525797
Recruitment Status : Unknown
Verified March 2015 by Baylor Research Institute.
Recruitment status was:  Active, not recruiting
First Posted : February 3, 2012
Last Update Posted : March 17, 2015
Information provided by (Responsible Party):
Baylor Research Institute

Brief Summary:
The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Condition or disease
Liver Transplant Recipients

Detailed Description:
The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 200 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Immunomonitoring of Transplant Patients
Study Start Date : October 2002
Estimated Primary Completion Date : November 2015
Estimated Study Completion Date : November 2015

Resource links provided by the National Library of Medicine


Primary Outcome Measures :
  1. Identify signatures predictive of graft rejection or tolerance. [ Time Frame: 2 years ]
    Analyze the pattern of gene expression in patients undergoing solid organ transplantation

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   17 Years to 65 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Liver Clinic

Inclusion Criteria:

  • Received a liver Transplant

Exclusion Criteria:

  • Received Multiple Organ Transplant

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01525797

Layout table for location information
United States, Texas
Baylor University Medical Center
Dallas, Texas, United States, 752245
Sponsors and Collaborators
Baylor Research Institute
Layout table for investigator information
Principal Investigator: Goran Klintmalm, MD Baylor Health Care System

Layout table for additonal information
Responsible Party: Baylor Research Institute Identifier: NCT01525797     History of Changes
Other Study ID Numbers: 002-197
First Posted: February 3, 2012    Key Record Dates
Last Update Posted: March 17, 2015
Last Verified: March 2015

Keywords provided by Baylor Research Institute:
Liver Transplant